Strategic partnership between Enzyre and Takeda
We advised Enzyre on its strategic partnership with Takeda whereby Takeda invested in Enzyre. Enzyre develops ground breaking ambulant diagnostic technology focused on blood coagulation.
Novish raises growth capital from QSRP
We advised Novish with its investment round in which it received growth capital from QRSP. Novish develops, produces and commercializes plant-based seafood products for the global retail and foodservice markets.
SET Ventures invests in Trunkrs
Wij advised SET Ventures with its investment in Trunkrs. The new financing round in which € 2,2 million was raised, was led by SET Ventures with participation of existing investor Ponooc. Trunkrs is conquering the Dutch market for same day and next day parcel deliveries at a rapid pace. Not only does the company offer fast and reliable deliveries, it also made it their mission to make parcel delivery sustainable.
Investment in econic
econic, active in the field of sustainable homes, has secured a new investment of 10 million euro from London-based investment office Rinkelberg Capital. We advised econic and its founder shareholders.
Financing round Cellpoint
We advised Cellpoint on its financing round, in which it raised growth capital from NanoDimension. CellPoint is active in the field of immuno-oncology and is developing a disruptive CAR-T production and supply model that allows cancer patients to be treated faster, more effectively and at lower cost.
Novalis invests in Enzyre
We advised Enzyre on an investment by Novalis Biotechnology Incubation. Novalis, through its seed fund, participated as co-financer in the Corona Bridge Loan granted by the Dutch government in support of innovative start-ups and scale-ups. Enzyre develops breakthrough ambulant diagnostic technology focused on blood coagulation.
Series A Financing of AMT Medical by Oost NL, NextGen Ventures and Utrecht Holdings (UU/UMCU)
We advised AMT Medical with its Series A financing by regional investor Oost NL and existing shareholders NextGen Ventures and Utrecht Holdings (UU / UMCU). AMT Medical is developing a unique coronary bypass system that enables safe, affordable and easy-to-use minimally invasive bypass surgery.
Flatfield sold to NCAB Group
We advised Standard Investment and the other shareholders of Flatfield with the sale of the shares in Flatfield to NCAB Group. Flatfield is de largest Dutch supplier of Printed Circuit Boards (PCBs). NCAB Group is one of the world’s largest suppliers of PCBs, with headquarter in Sweden and listed at NASDAQ Stockholm. NCAB Group strengthens its position in the Benelux and Germany with the acquisition of Flatfield.
Sale of Gebr. Van der Steen Bedrijven to Van Dorp Groep
We advised the shareholder of Gebr. Van der Steen Bedrijven in the sale of the family business to Van Dorp Groep. Gebr. Van der Steen is specialised in building, managing and maintaining infrastructure under and above ground.
SET Ventures invests in Flexidao
We advised SET Ventures on its investment in Flexidao, a start-up in the field of energy and blockchain. Existing shareholder KIC Innoenergy also participated in this round. With this investment Flexidao wants to accelerate the international growth of its blockchain-based energy delivery service and develop new use cases based on the existing middleware platform.